Cargando…
Profiling of normal and malignant breast tissue show CD44(high)/CD24(low) phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
BACKGROUND: Accumulating evidence supports cancer to initiate and develop from a small population of stem-like cells termed as cancer stem cells (CSC). The exact phenotype of CSC and their counterparts in normal mammary gland is not well characterized. In this study our aim was to evaluate the pheno...
Autores principales: | Ghebeh, Hazem, Sleiman, Ghida Majed, Manogaran, Pulicat S, Al-Mazrou, Amer, Barhoush, Eman, Al-Mohanna, Falah H, Tulbah, Asma, Al-Faqeeh, Khalid, Adra, Chaker N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702414/ https://www.ncbi.nlm.nih.gov/pubmed/23768049 http://dx.doi.org/10.1186/1471-2407-13-289 |
Ejemplares similares
-
Differential marker expression by cultures rich in mesenchymal stem cells
por: Wetzig, Andrew, et al.
Publicado: (2013) -
Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
por: Al-Alwan, Monther, et al.
Publicado: (2011) -
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
por: Ghebeh, Hazem, et al.
Publicado: (2010) -
PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
por: Mansour, Fatmah A., et al.
Publicado: (2020) -
Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma
por: Al-Rajhi, Nasser, et al.
Publicado: (2021)